<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">932172</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.932172</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products</article-title>
<alt-title alt-title-type="left-running-head">Tan et al.</alt-title>
<alt-title alt-title-type="right-running-head">Cordyceps and Related Products</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1301543/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yunyan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dai</surname>
<given-names>Hongmei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Junhui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1179591/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Zhifen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Lirong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1219333/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Jurong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1181622/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Nephrology</institution>, <institution>The Third Affiliated Hospital of Chongqing Medical University</institution>, <addr-line>Chongqing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Nephrology</institution>, <institution>YunYang County People&#x2019;s Hospital</institution>, <addr-line>Chongqing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/513594/overview">Zhiyong Guo</ext-link>, Second Military Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1815899/overview">Lianli Shen</ext-link>, Shanghai University of Traditional Chinese Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/848580/overview">Noha Mohammed Saeed</ext-link>, Egyptian Russian University, Egypt</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1103285/overview">Chengguo Wei</ext-link>, Mount Sinai Hospital, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jurong Yang, <email>yjr923@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors share first authorship</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Renal Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>07</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>932172</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>04</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>06</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Tan, Wang, Dai, Deng, Wu, Lin and Yang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Tan, Wang, Dai, Deng, Wu, Lin and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>At present, there is no effective drug for the treatment of renal fibrosis; in particular, a safe and effective treatment for renal fibrosis should be established. Cordyceps has several medical effects, including immunoregulatory, antitumor, anti-inflammatory, and antioxidant effects, and may prevent kidney, liver, and heart diseases. Cordyceps has also been reported to be effective in the treatment of renal fibrosis. In this paper, we review the potential mechanisms of Cordyceps against renal fibrosis, focusing on the effects of Cordyceps on inflammation, oxidative stress, apoptosis, regulation of autophagy, reduction of extracellular matrix deposition, and fibroblast activation. We also discuss relevant published clinical trials and meta-analyses. Available clinical studies support the possibility that Cordyceps and related products provide benefits to patients with chronic kidney diseases as adjuvants to conventional drugs. However, the existing clinical studies are limited by low quality and significant heterogeneity. The use of Cordyceps and related products may be a potential strategy for the treatment of renal fibrosis. Randomized controlled trial studies with good methodological quality, favorable experimental design, and large sample size are needed to evaluate the efficacy and safety of Cordyceps.</p>
</abstract>
<kwd-group>
<kwd>cordyceps</kwd>
<kwd>renal fibrosis</kwd>
<kwd>Chinese herbal medicine</kwd>
<kwd>chronic kidney disease</kwd>
<kwd>mechanism</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Renal fibrosis (RF) is a common outcome of the progression of various chronic kidney diseases (CKD) and the main pathological change in the progression of CKD to end-stage renal disease (<xref ref-type="bibr" rid="B26">Humphreys, 2018</xref>). It includes glomerulosclerosis (GS), renal interstitial fibrosis (RIF), and arteriosclerosis and perivascular fibrosis (<xref ref-type="bibr" rid="B14">Djudjaj and Boor, 2019</xref>). It shows histopathological features of excessive extracellular matrix (ECM) deposition, tubular atrophy, inflammatory cell infiltration, and loss of peritubular microvasculature. Subsequent structural destruction and functional impairment of the organ occurs, with scarring and sclerosis of the renal parenchyma. Cells involved in this event include renal tubular epithelial cells (TECs), endothelial cells (ECs), fibroblasts, pericytes, macrophages, and mast cells (<xref ref-type="bibr" rid="B66">Sun et al., 2016</xref>; <xref ref-type="bibr" rid="B83">Yan et al., 2021</xref>). In addition, cellular and molecular events such as inflammatory injury, oxidative stress, apoptosis, fibroblast activation, and epithelial&#x2013;mesenchymal transition (EMT) are closely associated with RF (<xref ref-type="bibr" rid="B39">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="B50">Nogueira et al., 2017</xref>). Despite significant progress in preclinical research of the mechanisms of RF and its therapeutic targets (<xref ref-type="bibr" rid="B50">Nogueira et al., 2017</xref>; <xref ref-type="bibr" rid="B2">Bai et al., 2021</xref>; <xref ref-type="bibr" rid="B83">Yan et al., 2021</xref>; <xref ref-type="bibr" rid="B59">Ruiz-Ortega et al., 2022</xref>), good target effects have not been demonstrated in clinical practice (<xref ref-type="bibr" rid="B71">Vincenti et al., 2017</xref>; <xref ref-type="bibr" rid="B72">Voelker et al., 2017</xref>). Therefore, there is still a lack of effective treatment that specifically targets RF. It is especially important to find safe and effective treatments for RF.</p>
<p>Chinese herbal medicines (CHMs) have been used for thousands of years in the treatment of kidney disease. Chinese herbs and fungi with potential kidney benefits include Cordyceps, Sairei-to, <italic>Rheum</italic> spp., <italic>Salvia miltiorrhiza</italic> and its components, and Magnesium lithospermate B (<xref ref-type="bibr" rid="B77">Wojcikowski et al., 2004</xref>). Anti-RF mechanisms of CHMs include anti-inflammatory and antioxidant effects, inhibition of EMT, reduction of ECM deposition, immune regulation, regulation of autophagy, inhibition of apoptosis, and control of hemorheology (<xref ref-type="bibr" rid="B92">Zhao et al., 2020</xref>). In this paper, we review the mechanisms of Cordyceps and related products in the treatment of RF (<xref ref-type="table" rid="T1">Table 1</xref>), as well as relevant clinical trials and meta-analyses (<xref ref-type="table" rid="T2">Table 2</xref>). We also discuss the possible nephrotoxicity of Cordyceps and the possible antifibrotic effects of the compounded formulation.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Mechanisms of Cordyceps and related products against renal fibrosis.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Compound/extract</th>
<th align="center">Animal/cell</th>
<th align="center">Model/inducer</th>
<th align="center">Outcomes</th>
<th align="center">Targets/pathway</th>
<th align="center">Mode of action</th>
<th align="center">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="8" align="left">CCP</td>
<td rowspan="6" align="left">SD rats</td>
<td rowspan="6" align="left">HFD &#x2b; STZ</td>
<td align="left">TNF-&#x3b1;&#x2193;, IL-1&#x3b2;&#x2193;, IL-6&#x2193;</td>
<td rowspan="8" align="left">Blocking the TLR4/NF-&#x3ba;B and TGF-&#x3b2;1/Smad signaling pathway</td>
<td rowspan="8" align="left">Anti-inflammatory; regulation of dysbiosis of gut microbiota</td>
<td rowspan="8" align="left">
<xref ref-type="bibr" rid="B85">Yang et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Inflammatory cell infiltration&#x2193;</td>
</tr>
<tr>
<td align="left">CTGF&#x2193;, MMP-2&#x2193;, HYP&#x2193;</td>
</tr>
<tr>
<td align="left">Collagen deposition&#x2193;</td>
</tr>
<tr>
<td align="left">a-SMA and Collagen I expression&#x2193;</td>
</tr>
<tr>
<td align="left">Regulation of dysbiosis of gut microbiota</td>
</tr>
<tr>
<td align="left">NRK-52E Cells</td>
<td align="left">LPS</td>
<td align="left">TNF-&#x3b1;&#x2193;, IL-1&#x3b2;&#x2193;, IL-6&#x2193;</td>
</tr>
<tr>
<td align="left">NRK-49F cells</td>
<td align="left">TGF-&#x3b2;</td>
<td align="left">Collagen I&#x2193;, Fibronectin&#x2193;, &#x3b1;-SMA&#x2193;</td>
</tr>
<tr>
<td rowspan="7" align="left">HEA</td>
<td rowspan="5" align="left">C57BL6/J mice</td>
<td rowspan="5" align="left">UUO</td>
<td align="left">Integrity of renal parenchymal cells&#x2191;</td>
<td rowspan="7" align="left">Inhibition of TGF-&#x3b2;1/Smad and NF-&#x3ba;B signaling pathways</td>
<td rowspan="7" align="left">Anti-inflammatory</td>
<td rowspan="7" align="left">
<xref ref-type="bibr" rid="B93">Zheng et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">Collagen deposition&#x2193;</td>
</tr>
<tr>
<td align="left">TGF-&#x3b2;1&#x2193;, &#x3b1;-SMA&#x2193;, collagen I&#x2193;, Fibronectin&#x2193;</td>
</tr>
<tr>
<td align="left">TNF-&#x3b1;&#x2193;, IL-6&#x2193;, IL-1&#x3b2;&#x2193;</td>
</tr>
<tr>
<td align="left">M1&#x2193;, M2&#x2191;</td>
</tr>
<tr>
<td align="left">RAW 264.7 cells</td>
<td align="left">LPS</td>
<td align="left">TNF-&#x3b1;&#x2193;,IL-1&#x3b2;&#x2193;, IL-10&#x2191;</td>
</tr>
<tr>
<td align="left">NRK-49F cells</td>
<td align="left">TGF-&#x3b2;</td>
<td align="left">Fibronectin&#x2193;,&#x3b1;-SMA&#x2193;, collagen I</td>
</tr>
<tr>
<td rowspan="3" align="left">HEA</td>
<td rowspan="3" align="left">SD rats</td>
<td rowspan="3" align="left">Alloxan monohydrate</td>
<td align="left">TNF-&#x3b1;&#x2193;, IL-1&#x3b2;&#x2193;, IL-6&#x2193;</td>
<td rowspan="3" align="left">Inhibition of TGF-&#x3b2;1 and NF-&#x3ba;B</td>
<td rowspan="3" align="left">Anti-inflammatory; antioxidative stress</td>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B76">Wang et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">SOD&#x2191;, CAT&#x2191;, GSH&#x2191;, MDA &#x2193;</td>
</tr>
<tr>
<td align="left">Tubular necrosis&#x2193;, inflammatory infiltration&#x2193;, thickening of the membrane basement&#x2193;</td>
</tr>
<tr>
<td align="left">Cordycepin</td>
<td align="left">HEK293T cells</td>
<td align="left">&#x2014;</td>
<td align="left">IL-1 &#x3b2;&#x2193;, TNF-&#x3b1;&#x2193;</td>
<td align="left">Inhibition of TLR4/NF-&#x3ba;B pathway</td>
<td align="left">Anti-inflammatory</td>
<td align="left">
<xref ref-type="bibr" rid="B65">Sun et al. (2019)</xref>
</td>
</tr>
<tr>
<td rowspan="3" align="left">Cordyceps cicadae/Paecilomyces cicadae</td>
<td rowspan="3" align="left">SD rats</td>
<td rowspan="3" align="left">250&#xa0;mg/kg adenine</td>
<td align="left">MDA&#x2193;, GSH&#x2193;, SOD&#x2191;</td>
<td rowspan="3" align="left">May be related to the downregulated PAI-1</td>
<td rowspan="3" align="left">Antioxidative stress; anti-inflammatory</td>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B30">Li et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Kidney indices&#x2193;, the number of the glomerulus&#x2191;</td>
</tr>
<tr>
<td align="left">Interstitial inflammation in the proximal and distal convoluted tubules&#x2193;</td>
</tr>
<tr>
<td rowspan="6" align="left">Ophiocordyceps Lanpingensis</td>
<td rowspan="6" align="left">C57BL/6 Mice</td>
<td rowspan="6" align="left">0.25% adenine</td>
<td align="left">Ameliorate the CKD pathological Changes</td>
<td rowspan="6" align="left">Inhibition of TLR4-mediated MAPK/NF-&#x3ba;B pathway</td>
<td rowspan="6" align="left">Antioxidative stress; anti-inflammatory Antiapoptosis</td>
<td rowspan="6" align="left">
<xref ref-type="bibr" rid="B95">Zhou et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Recruitment of macrophages&#x2193;</td>
</tr>
<tr>
<td align="left">SOD&#x2191;, GSH-PX&#x2191;, ROS&#x2193;, MDA&#x2193;</td>
</tr>
<tr>
<td align="left">TNF-&#x3b1;&#x2193;, IL-1&#x3b2;&#x2193;, IL-10&#x2191;</td>
</tr>
<tr>
<td align="left">Apoptosis cells&#x2193;, BAX&#x2193;, Caspase-3&#x2193;, Caspase-9&#x2193;, Bcl-2&#x2191;</td>
</tr>
<tr>
<td align="left">Tissue fibrosis&#x2193;, TGF-&#x3b2;1 expression&#x2193;, &#x3b1;-SMA&#x2193;, collagen I&#x2193;</td>
</tr>
<tr>
<td rowspan="2" align="left">HEA</td>
<td rowspan="2" align="left">HK-2 cells</td>
<td rowspan="2" align="left">NSAIDs diclofenac/meloxicam</td>
<td align="left">ROS&#x2193;</td>
<td rowspan="2" align="left">Regulates the GRP78/ATF6/PERK/IRE1&#x3b1;/CHOP pathway</td>
<td rowspan="2" align="left">Antioxidative stress; antiapoptosis</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B10">Chyau et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Apoptosis cells&#x2193;</td>
</tr>
<tr>
<td rowspan="2" align="left">
<italic>Cordyceps militaris</italic>
</td>
<td rowspan="2" align="left">SD rats</td>
<td rowspan="2" align="left">HFD &#x2b; STZ</td>
<td align="left">SOD&#x2191;, GSH-px&#x2191;, ROS&#x2193;, MDA&#x2193;</td>
<td rowspan="2" align="left">Phosphor-AKT&#x2193; phosphor-GSK-3&#x3b2;&#x2193;</td>
<td rowspan="2" align="left">Antioxidative stress; anti-inflammatory</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B37">Liu et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">Inflammatory infiltrate&#x2193;</td>
</tr>
<tr>
<td rowspan="2" align="left">
<italic>Cordyceps cicadae</italic>
</td>
<td align="left">SHR/WK rats</td>
<td align="left">SHR</td>
<td align="left">Collagen deposition&#x2193;, a-SMA&#x2193;</td>
<td rowspan="2" align="left">Inhibition of SIRT1/p53 pathway</td>
<td rowspan="2" align="left">Antiapoptosis</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B25">Huang et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Primary human RPTEC</td>
<td align="left">AngII</td>
<td align="left">Apoptosis cells&#x2193;, Caspase-3&#x2193;</td>
</tr>
<tr>
<td rowspan="5" align="left">CMP</td>
<td rowspan="5" align="left">C57BL/6 mice</td>
<td rowspan="5" align="left">STZ</td>
<td align="left">Collagen deposition&#x2193;</td>
<td rowspan="5" align="left">&#x2014;</td>
<td rowspan="5" align="left">Activation of autophagy; anti-inflammatory; antioxidative stress</td>
<td rowspan="5" align="left">
<xref ref-type="bibr" rid="B7">Chen et al. (2019a)</xref>
</td>
</tr>
<tr>
<td align="left">CD68&#x2193;, IL-1&#x3b2;&#x2193;, IL-6&#x2193;, MCP-1&#x2193;</td>
</tr>
<tr>
<td align="left">Autophagosome&#x2191;</td>
</tr>
<tr>
<td align="left">Atg5&#x2191;, beclin1&#x2191;, LC3&#x2191;, p62&#x2193;</td>
</tr>
<tr>
<td align="left">GSH&#x2191;, MDA&#x2193;</td>
</tr>
<tr>
<td rowspan="7" align="left">
<italic>Cordyceps cicadae</italic>
</td>
<td rowspan="5" align="left">SHR/WK rats</td>
<td rowspan="5" align="left">SHR</td>
<td align="left">Collagen deposition&#x2193;</td>
<td rowspan="7" align="left">Activation of SIRT1/FOXO3a/ROS</td>
<td rowspan="7" align="left">Inhibition of autophagy; antioxidative stress</td>
<td rowspan="7" align="left">
<xref ref-type="bibr" rid="B5">Cai et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">TGF&#x3b2;1&#x2193;, &#x3b1;-SMA&#x2193;, fibronectin&#x2193;, collagen I&#x2193;</td>
</tr>
<tr>
<td align="left">Apoptosis cells&#x2193;</td>
</tr>
<tr>
<td align="left">LC3II&#x2193;, beclin-1&#x2193;, SQSTM1/p62&#x2193;</td>
</tr>
<tr>
<td align="left">SOD&#x2191;, MDA &#x2193;</td>
</tr>
<tr>
<td rowspan="2" align="left">NRK-52E cells</td>
<td rowspan="2" align="left">AngII/rapamycin</td>
<td align="left">Collagen I&#x2193;, &#x3b1;-SMA&#x2193;</td>
</tr>
<tr>
<td align="left">LC3II&#x2193;, beclin-1&#x2193;</td>
</tr>
<tr>
<td rowspan="6" align="left">Nucleoside/nucleobase extract</td>
<td rowspan="3" align="left">C57BL/6 mice</td>
<td rowspan="3" align="left">STZ</td>
<td align="left">Collagen deposition&#x2193;</td>
<td rowspan="6" align="left">Phosphor-p38&#x2193; phosphor-ERK&#x2193;</td>
<td rowspan="6" align="left">Inhibition of EMT and ECM deposition</td>
<td rowspan="6" align="left">
<xref ref-type="bibr" rid="B17">Dong et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Fibronectin&#x2193;, collagen I&#x2193;</td>
</tr>
<tr>
<td align="left">E-cadherin&#x2191;, &#x3b1;-SMA&#x2193;</td>
</tr>
<tr>
<td rowspan="3" align="left">HK-2 cells</td>
<td rowspan="3" align="left">HG</td>
<td align="left">Morphological and phenotypic changes&#x2193;</td>
</tr>
<tr>
<td align="left">E-cadherin&#x2191;, &#x3b1;-SMA&#x2193;</td>
</tr>
<tr>
<td align="left">Fibronectin&#x2193;, collagen I&#x2193;</td>
</tr>
<tr>
<td rowspan="2" align="left">Ergosterol peroxide</td>
<td rowspan="2" align="left">NRK-49F cells</td>
<td rowspan="2" align="left">TGF-&#x3b2;1</td>
<td align="left">Renal fibroblast proliferation rate&#x2193;</td>
<td rowspan="2" align="left">Blocking the phosphorylation of ERK1/2, p38, and JNK pathway</td>
<td rowspan="2" align="left">Ameliorates TGF-&#x3b2;1-induced activation of kidney fibroblasts</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B97">Zhu et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Fibronectin&#x2193;, a-SMA&#x2193;, vimentin&#x2193;, CTGF&#x2193;</td>
</tr>
<tr>
<td align="left">CmNo1 extract</td>
<td align="left">C57BL/6J mice</td>
<td align="left">HFD &#x2b; STZ</td>
<td align="left">Collagen IV&#x2193;</td>
<td align="left">TGF-&#x3b2;1&#x2193;</td>
<td align="left">Inhibition of collagen deposition</td>
<td align="left">
<xref ref-type="bibr" rid="B88">Yu et al. (2016)</xref>
</td>
</tr>
<tr>
<td rowspan="3" align="left">
<italic>Cordyceps sinensis</italic>
</td>
<td rowspan="3" align="left">SD rats</td>
<td rowspan="3" align="left">5/6 nephrectomy</td>
<td align="left">Interstitial fibrosis&#x2193;</td>
<td rowspan="3" align="left">Inhibition of TGF-&#x3b2;1/Smad pathway</td>
<td rowspan="3" align="left">Inhibition of EMT and ECM deposition</td>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B52">Pan et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">E-cadherin&#x2191;, &#x3b1;-SMA&#x2193;, FSP1&#x2193;</td>
</tr>
<tr>
<td align="left">TGF-&#x3b2;1&#x2193;, T&#x3b2;R1&#x2193;, T&#x3b2;R2&#x2193;, Smad2&#x2193;, Smad3&#x2193;, Smad7&#x2191;</td>
</tr>
<tr>
<td rowspan="3" align="left">3&#x2032;-Deoxyadenosine</td>
<td rowspan="2" align="left">C57BL/6 mice</td>
<td rowspan="2" align="left">UUO</td>
<td align="left">Collagen I&#x2193;, &#x3b1;-SMA&#x2193;</td>
<td rowspan="3" align="left">Reduced phosphorylation and total Smads through transcriptional repression</td>
<td rowspan="3" align="left">Inhibition of ECM deposition</td>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B21">Gu et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">Interstitial myofibroblasts&#x2193;, fibrotic area&#x2193;</td>
</tr>
<tr>
<td align="left">NRK-52E</td>
<td align="left">TGF-&#x3b2;/BMP-4</td>
<td align="left">Collagen I&#x2193;, collagen IV&#x2193;</td>
</tr>
<tr>
<td align="left">
<italic>Cordyceps sinensis</italic>
</td>
<td align="left">SD rats</td>
<td align="left">UUO</td>
<td align="left">Interstitial collagen deposition Masson&#x2193;, &#x3b1;-SMA&#x2193;</td>
<td align="left">BAG3&#x2193;</td>
<td align="left">Inhibition of EMT and ECM deposition</td>
<td align="left">
<xref ref-type="bibr" rid="B18">Du et al. (2015)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left">
<italic>Hirsutella sinensis</italic>
</td>
<td rowspan="2" align="left">C57BL/Ks mice</td>
<td rowspan="2" align="left">db/db diabetic</td>
<td align="left">Interstitial fibrosis&#x2193;</td>
<td rowspan="2" align="left">Metabolites of the TCA cycle, glycolysis, pentose phosphate pathway, pyrimidine metabolism, and purine metabolism&#x2193;</td>
<td rowspan="2" align="left">Regulation of disturbed metabolome</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B43">Lu et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">TGF- &#x3b2;1&#x2193;, CTGF&#x2193;, VEGF&#x2193;, fibronectin&#x2193;, collagen I&#x2193;, collagen IV&#x2193;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>HFD, high-fat diet; TNF, tumor necrosis factor; IL-1, interleukin 1; IL-6, interleukin 1; CTGF, connective tissue growth factor; MMP-2, matrix metalloproteinase-2; HYP, hydroxyproline; a-Smooth muscle actin, a-shape memory alloy; TLR4, Toll-like receptor 4; NF-&#x3ba;B, Nuclear factor-kappaB; TGF-&#x3b2;1, transforming growth factor beta1; SOD, superoxide dismutase; CAT, catalase; GSH, glutathione; MDA, malondialdehyde; ROS, reactive oxygen species; Bcl-2, B-cell chronic lymphocytic leukemia/lymphoma-2; BAX, Bcl-2-associated X protein; GRP78, glucose-regulated protein 78; ATF6, activating transcription factor 6; PERK, protein kinase R (PKR)-like endoplasmic reticulum kinase; IRE1&#x3b1;, inositol-requiring enzyme 1 alpha; CHOP, C/EBP homologous protein; SHR, spontaneously hypertensive; RPTEC, renal proximal tubular epithelial cells; WK, wistar-kyoto; SIRT1, Sirtuin-1; MCP-1, monocyte chemoattractant protein-1; Atg5, Autophagy Protein 5; LC3, light chain 3; SQSTM1, sequestosome1; FOXO3a, forkhead box class O3a; HG, high glucose; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; CmNo1, cordyceps militaris No.1; FSP1, ferroptosis suppressor protein 1; EMT, epithelial&#x2013;mesenchymal transition; ECM, extracellular matrix; BAG3, Bcl-2-associated athanogene 3; VEGF, vascular endothelial growth factor; TCA, tricarboxylic acid.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Clinical studies with Cordyceps.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Study type</th>
<th align="center">N</th>
<th align="center">Therapeutic arms</th>
<th align="center">Disease</th>
<th align="center">Duration</th>
<th align="center">Outcomes</th>
<th align="center">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="5" align="left">RCT</td>
<td rowspan="5" align="center">98</td>
<td rowspan="5" align="left">COG vs. CG</td>
<td rowspan="5" align="left">CKD late stage 3 or stage 4</td>
<td rowspan="5" align="left">3&#xa0;months</td>
<td align="left">In COG group</td>
<td rowspan="5" align="left">
<xref ref-type="bibr" rid="B65">Sun et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Inflammatory state and thickness of glomerular filtration membrane in renal tissue&#x2191;</td>
</tr>
<tr>
<td align="left">Urinal protein&#x2193; BUN&#x2193;, creatinine&#x2193;, EGFR&#x2191; (<italic>p</italic> &#x3c; 0.05)</td>
</tr>
<tr>
<td align="left">TG&#x2193;, TC&#x2193;, LDL-C&#x2193;, HDL-C&#x2191; (<italic>p</italic> &#x3c; 0.05)</td>
</tr>
<tr>
<td align="left">Cys-C &#x2193;, MPO &#x2193;, MDA &#x2193;, NO &#x2191;, SOD &#x2191; (<italic>p</italic> &#x3c; 0.05)</td>
</tr>
<tr>
<td rowspan="5" align="left">Study cohort</td>
<td rowspan="5" align="center">160</td>
<td rowspan="5" align="left">Bailing capsules &#x2b; losartan vs. losartan</td>
<td rowspan="5" align="left">Diabetic glomerulosclerosis</td>
<td rowspan="5" align="left">&#x2014;</td>
<td align="left">In Bailing capsules &#x2b; losartan group</td>
<td rowspan="5" align="left">
<xref ref-type="bibr" rid="B89">Yu et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">ORR&#x2191;, 91.25% vs. 78.75%</td>
</tr>
<tr>
<td align="left">DBP&#x2193;, SBP&#x2193;, Scr&#x2193;, BUN&#x2193;, 24&#xa0;h UP&#x2193;, mALB&#x2193;, &#x3b2;2-MG&#x2193;,GFR&#x2191; (<italic>p</italic> &#x3c; 0.01)</td>
</tr>
<tr>
<td align="left">TCM points&#x2193; (<italic>p</italic> &#x3c; 0.01)</td>
</tr>
<tr>
<td align="left">SOD&#x2191;, ROS&#x2193;, 8-OHdG&#x2193;, hs-CRP&#x2193;, TGF-&#x3b2;1&#x2193;, SAA&#x2193; (<italic>p</italic> &#x3c; 0.01)</td>
</tr>
<tr>
<td rowspan="2" align="left">Review</td>
<td rowspan="2" align="center">1746</td>
<td rowspan="2" align="left">Cordyceps vs. placebo, no treatment, or conventional treatment</td>
<td rowspan="2" align="left">CKD</td>
<td rowspan="2" align="left">&#x2014;</td>
<td align="left">In Cordyceps group</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B90">Zhang et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Scr&#x2193; (14 studies, 987 participants), Ccr&#x2191; (6 studies, 362 participants), 24&#xa0;h UP &#x2193; (4 studies, 211 participants)</td>
</tr>
<tr>
<td rowspan="4" align="left">Meta-analysis</td>
<td rowspan="4" align="center">3955</td>
<td rowspan="4" align="left">JSB capsules &#x2b; ACEI/ARB vs. ACEI/ARB</td>
<td rowspan="4" align="left">Diabetic kidney disease</td>
<td rowspan="4" align="left">28&#xa0;days&#x2013;4&#xa0;weeks</td>
<td align="left">In JSB combined with ACEI/ARB group</td>
<td rowspan="4" align="left">
<xref ref-type="bibr" rid="B32">Li and Xu, (2020)</xref>
</td>
</tr>
<tr>
<td align="left">ORR&#x2191; (OR 4.91; 95% CI 3.32&#x2013;7.25)</td>
</tr>
<tr>
<td align="left">24&#xa0;h UP&#x2193;, UAER&#x2193;, Scr&#x2193;, BUN&#x2193; (<italic>p</italic> &#x3c; 0.0001)</td>
</tr>
<tr>
<td align="left">SBP&#x2193;, DBP&#x2193;,FBG&#x2193;, HA1c&#x2193;, TC&#x2193;, TG&#x2193;</td>
</tr>
<tr>
<td rowspan="4" align="left">Meta-analysis</td>
<td rowspan="4" align="center">2198</td>
<td rowspan="4" align="left">JSB &#x2b; ARBs vs. ARBs</td>
<td rowspan="4" align="left">Early diabetic Nephropathy</td>
<td rowspan="4" align="left">8&#x2013;28&#xa0;weeks</td>
<td align="left">In JSB &#x2b; ARBs group</td>
<td rowspan="4" align="left">
<xref ref-type="bibr" rid="B42">Lu et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">ORR &#x2191; (OR 3.84; 95% CI: 2.37&#x2013;6.24; <italic>p</italic> &#x3c; 0.000001)</td>
</tr>
<tr>
<td align="left">24&#xa0;h UTP&#x2193;, UAER&#x2193;, ACR&#x2193;, Cys-C&#x2193;, TG&#x2193; (<italic>p</italic> &#x3c; 0.000001),</td>
</tr>
<tr>
<td align="left">BUN&#x2193; (<italic>p</italic> &#x3d; 0.005), Scr&#x2193; (<italic>p</italic> &#x3d; 0.0006), SBP&#x2193; (<italic>p</italic> &#x3d; 0.0001), DBP&#x2193; (<italic>p</italic> &#x3d; 0.03)</td>
</tr>
<tr>
<td rowspan="4" align="left">Meta-analysis</td>
<td rowspan="4" align="center">4288</td>
<td rowspan="4" align="left">
<italic>Ophiocordyceps sinensis</italic> &#x2b; ACEI/ARB vs. ACEI/ARB</td>
<td rowspan="4" align="left">Diabetic kidney disease</td>
<td rowspan="4" align="left">4&#x2013;24&#xa0;weeks</td>
<td align="left">In <italic>Ophiocordyceps sinensis</italic> &#x2b; ACEI/ARB group</td>
<td rowspan="4" align="left">
<xref ref-type="bibr" rid="B44">Luo et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">24&#xa0;h UP&#x2193;, UAER&#x2193;, MAU&#x2193;, CRP&#x2193;, TG&#x2193;, TC&#x2193; (<italic>p</italic> &#x3c; 0.000001)</td>
</tr>
<tr>
<td align="left">BUN&#x2193;, Scr&#x2193; (<italic>p</italic> &#x3c; 0.0001)</td>
</tr>
<tr>
<td align="left">SBP&#x2193; (<italic>p</italic> &#x3d; 0.006)</td>
</tr>
<tr>
<td rowspan="3" align="left">Meta-analysis</td>
<td rowspan="3" align="center">1941</td>
<td rowspan="3" align="left">Bailing capsules &#x2b; control group treatment vs. routine treatment, and/or combined with Western medicine</td>
<td rowspan="3" align="left">Type 2 diabetic nephropathy</td>
<td rowspan="3" align="left">4&#x2013;24&#xa0;weeks</td>
<td align="left">In the group containing Bailing capsules</td>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B61">Sheng et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">ORR &#x2191; (OR &#x3d; 1.24; 95% CI: 1.11&#x2013;1.38)</td>
</tr>
<tr>
<td align="left">24 h urine total protein&#x2193;, UAER&#x2193;, Scr&#x2193;, BUN&#x2193; (<italic>p</italic> &#x3c; 0.01)</td>
</tr>
<tr>
<td align="left">RCT</td>
<td align="center">97</td>
<td align="left">HEA-enriched <italic>Cordyceps cicadae</italic> Mycelium vs. placebo</td>
<td align="left">&#x2014;</td>
<td align="left">3&#xa0;months</td>
<td align="left">No differences in symptoms or side effects between participants. There was also no significant difference between baseline measurements and the final analysis of biochemical analysis, such as kidney function, liver function, and blood electrolytes</td>
<td align="left">
<xref ref-type="bibr" rid="B70">Tsai et al. (2021)</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>COG, cordycepin group; CG, control group; GFR, glomerular filtration rates; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, low-density lipoprotein cholesterol; Cys-C, cystatin-C; MPO, myeloperoxidase; MDA, malondialdehyde; NO, nitric oxide; SOD, superoxide dismutase; DBP, diastolic blood pressure; SBP, systolic blood pressure; Scr, serum creatinine; BUN, blood urea nitrogen; 24&#xa0;h UP, 24&#xa0;h urine protein; mALB, urine microalbumin; &#x3b2;2-MG, &#x3b2;2 microglobulin; TCM, traditional chinese medicine; ROS, reactive oxygen species; 8-OhdG, 8-hydroxydeoxyguanine; hs-CRP, hypersensitive C-reactive protein; TGF-&#x3b2;1, transforming growth factor &#x3b2;1; SAA, serum amyloid A; Ccr, creatinine clearance; FBG, fasting blood glucose; HA1c, hemoglobin A1c; JSB, jinshuibao; CI, confidence interval; MD, mean difference; ORR, overall response rate; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; 24&#xa0;h UTP, 24&#xa0;h urinary total protein; UAER, urinary albumin excretion rate; ACR, albumin-to-creatinine ratio; MAU, microalbuminuria.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Cordyceps is a fungus that colonizes the larvae of moths. It has been used for centuries as a medicine in China, Japan, and other Asian countries. It has several species, including <italic>Cordyceps sinensis</italic>, <italic>Cordyceps militaris</italic>, and <italic>Cordyceps cicadae</italic>. Cordyceps has a variety of medicinal properties or bioactive compounds, including nucleosides, polysaccharides, cyclodepsipeptides, sterols, alkaloids, and phenolics (<xref ref-type="bibr" rid="B51">Olatunji et al., 2018</xref>), which show immunomodulatory, antitumor, anti-inflammatory, antioxidant, renoprotective, and other effects (<xref ref-type="bibr" rid="B12">Das et al., 2020</xref>). Cordyceps has shown potential promise as an adjunct to conventional medicine to decrease serum creatinine (Scr), increase creatinine clearance, reduce proteinuria, and alleviate CKD-related complications (<xref ref-type="bibr" rid="B90">Zhang et al., 2014</xref>). Based on the network pharmacology tools that are used to investigate the molecular mechanism of Cordyceps for the treatment of diabetic nephropathy (DN), seven active ingredients were screened from Cordyceps, 293 putative target genes were identified, and 85 overlapping targets matching DN were identified as potential therapeutic targets, such as tumor necrosis factor (TNF), mitogen-activated protein kinase 1, epidermal growth factor receptor (EGFR), angiotensin-converting enzyme, and Caspase-9. Cordyceps are involved in an inflammatory response, apoptosis, oxidative stress, insulin resistance, and other biological processes through these pathways (<xref ref-type="bibr" rid="B33">Li et al., 2021</xref>).</p>
</sec>
<sec id="s2">
<title>Mechanisms of Cordyceps and Related Products Against Renal Fibrosis</title>
<sec id="s2-1">
<title>Cordyceps Relieves Inflammation</title>
<p>Inflammation is the initiator of RF, and persistent chronic inflammation is considered a hallmark feature of CKD (<xref ref-type="bibr" rid="B47">Meng, 2019</xref>). In response to pathogenic factors, damaged renal TECs recruit inflammatory cells to the renal interstitial region, and these inflammatory cells then produce large amounts of proinflammatory and profibrotic cytokines (<xref ref-type="bibr" rid="B20">Gewin et al., 2017</xref>). Various active ingredients in Cordyceps have anti-inflammatory effects (<xref ref-type="bibr" rid="B55">Phull et al., 2022</xref>). They have been shown to protect against liver fibrosis through anti-inflammatory effects (<xref ref-type="bibr" rid="B81">Xu et al., 2021</xref>) (<xref ref-type="bibr" rid="B87">Ying-Mei et al., 2020</xref>). Cordyceps extract attenuates renal histological changes, reduces Scr and blood urea nitrogen (BUN) levels, and decreases inflammatory factors in acute kidney injury (AKI), including renal ischemia/reperfusion injury (<xref ref-type="bibr" rid="B22">Han et al., 2020</xref>) and cisplatin-induced AKI (<xref ref-type="bibr" rid="B13">Deng et al., 2020</xref>). In RF related to streptozotocin (STZ), or alloxan monohydrate&#x2013;induced DN, the active components of Cordyceps, <italic>Cordyceps cicadae</italic> polysaccharides (CCP) or N<sup>6</sup>-(2-hydroxyethyl) adenosine (HEA), are effective in reducing the expression of proinflammatory factors TNF-&#x3b1;, IL-1&#x3b2;, and IL-6 in serum and kidney and in reducing the expression of interstitial fibrosis-associated proteins &#x3b1;-SMA and collagen I (<xref ref-type="bibr" rid="B76">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="B85">Yang et al., 2020</xref>). <italic>In vitro</italic>, CCP also reduces the release of lipopolysaccharide-induced proinflammatory factors and TGF-&#x3b2;-induced activation of fibroblasts (<xref ref-type="bibr" rid="B85">Yang et al., 2020</xref>). Unilateral ureteral obstruction (UUO) is a classical RF model, and Cordyceps extract HEA reduces fibrosis-associated proteins TGF-&#x3b2;1, &#x3b1;-SMA, collagen I, and fibronectin, and inflammatory factors TNF-&#x3b1;, IL-6, and IL-1&#x3b2; in renal tissue 14&#xa0;days after UUO (<xref ref-type="bibr" rid="B93">Zheng et al., 2018</xref>). <xref ref-type="bibr" rid="B93">Zheng et al.&#x2019;s (2018)</xref> study initially explored the effect of HEA on inflammatory cells and found that HEA blocked the accumulation of M1 macrophages and induced the accumulation of M2 macrophages in the kidney as reflected by the positive detection of the F4/80 antigen. The role of M2 macrophages in fibrosis is controversial (<xref ref-type="bibr" rid="B57">Ricardo et al., 2008</xref>) (<xref ref-type="bibr" rid="B35">Lin et al., 2010</xref>), but the M1/M2 macrophage ratio is an important stage in the development of RIF. However, this study did not further distinguish between the subtypes of M2.</p>
<p>The abovementioned studies have explored the regulatory mechanism of Cordyceps extract against inflammation in RF by inhibiting the TGF-&#x3b2;1/Smad and TLR4/NF-&#x3ba;B signaling pathways (<xref ref-type="bibr" rid="B93">Zheng et al., 2018</xref>; <xref ref-type="bibr" rid="B85">Yang et al., 2020</xref>). Sun et al. found that p-TLR4, TLR4, p-NF-&#x3ba;B, NF-&#x3ba;B, IL-1 &#x3b2;, and TNF-&#x3b1; levels were effectively reduced by Cordycepin treatment in human embryonic kidney 293T cells. However, Cordycepin did not reduce the levels of these molecules when TLR4 was silenced. These results suggest that Cordycepin may affect the NF-&#x3ba;B signaling pathway through TLR4 (<xref ref-type="bibr" rid="B65">Sun et al., 2019</xref>). TLRs/NF-&#x3ba;B activate the downstream inflammasome NOD-like receptor family pyrin domain containing 3 (NLRP3) (<xref ref-type="bibr" rid="B82">Xue et al., 2019</xref>), which promotes the maturation of proinflammatory factors IL-1&#x3b2; and IL-18 by activating Caspase-1 (<xref ref-type="bibr" rid="B36">Liston and Masters, 2017</xref>). Multiple studies have shown that the NLRP3 inflammasome and its downstream pyroptosis and inflammation play an important role in the development of RF (<xref ref-type="bibr" rid="B46">Ma et al., 2022</xref>) (<xref ref-type="bibr" rid="B56">Ram et al., 2022</xref>; <xref ref-type="bibr" rid="B75">Wang et al., 2022</xref>). It has been shown that <italic>Ophiocordyceps sinensis</italic> causes inhibition of mRNA and protein expression of NLRP3 inflammasome and downstream effectors IL-1&#x3b2; and IL-18 in a rat model of DN (<xref ref-type="bibr" rid="B74">Wang et al., 2018</xref>). Thus, Cordyceps and related products are effective in relieving inflammation in RF through multiple mechanisms.</p>
</sec>
<sec id="s2-2">
<title>Cordyceps Attenuates Oxidative Stress</title>
<p>The kidney is a highly metabolically active organ with mitochondria rich in oxidative reactions and susceptible to oxidative stress damage. Oxidative stress and inflammation interact to play a key role in renal tissue destruction, irreversible loss of renal function, and progression of RF (<xref ref-type="bibr" rid="B80">Xu et al., 2015</xref>; <xref ref-type="bibr" rid="B11">Darby and Hewitson, 2016</xref>; <xref ref-type="bibr" rid="B58">Richter and Kietzmann, 2016</xref>). Normal cells produce small amounts of reactive oxygen species (ROS), which play an important physiological role. Free radical&#x2013;scavenging enzymes and antioxidants maintain oxygen metabolism homeostasis by activating transcription factors, regulating physiologically active substances and inflammatory immunity, and promoting cell proliferation and differentiation. Oxidative stress occurs when the balance between ROS and reactive nitrogen species and the antioxidant defense system is disrupted, that is, when the production of pro-oxidants or ROS exceeds the endogenous antioxidant capacity (<xref ref-type="bibr" rid="B62">Sies et al., 2017</xref>). It has been shown that oxidative stress promotes the progression of RF (<xref ref-type="bibr" rid="B1">Aranda-Rivera et al., 2021</xref>); if oxidative stress is suppressed, RF can be attenuated (<xref ref-type="bibr" rid="B34">Liao et al., 2022</xref>; <xref ref-type="bibr" rid="B41">Lo et al., 2022</xref>). Antioxidant enzymes, such as superoxide dismutase (SOD), catalase, and glutathione peroxidase (GSH-Px), protect cells from damage caused by oxygen free radicals. Malondialdehyde (MDA) is one of the products of the reaction between lipids and oxygen free radicals, and it accumulates during oxidative stress. Cordyceps improves the redox properties of CKD by affecting the levels of NO, SOD, and MDA in serum. In rat models of DN (<xref ref-type="bibr" rid="B37">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B76">Wang et al., 2019</xref>) and membranous nephropathy (<xref ref-type="bibr" rid="B63">Song et al., 2016</xref>), both <italic>C. militaris</italic> and HEA showed excellent ability to attenuate oxidative stress, elevated SOD and GSH, and decreased MDA levels. Using diclofenac or meloxicam to induce oxidative stress, HEA intervention significantly reduced the level of ROS in human proximal tubular cells (HK-2) cells (<xref ref-type="bibr" rid="B10">Chyau et al., 2021</xref>). In rats with adenine-induced chronic renal failure, <italic>Cordyceps cicadae</italic> and <italic>Paecilomyces cicadae</italic> effectively reduced serum urea and creatinine levels, improved renal histopathology, inhibited oxidative stress, and enhanced antioxidant capacity (<xref ref-type="bibr" rid="B30">Li et al., 2019</xref>). In a CKD mouse model established by adenine gavage, <italic>Ophiocordyceps lanpingensis</italic> polysaccharides elevated SOD and GSH-PX, decreased ROS and MDA, improved histopathological staining, and decreased fibrosis-related proteins TGF-&#x3b2;1, &#x3b1;-SMA, and collagen I (<xref ref-type="bibr" rid="B95">Zhou et al., 2021</xref>). Cordyceps and related products have a favorable ability to attenuate oxidative stress, but the mechanisms involved are not well understood.</p>
</sec>
<sec id="s2-3">
<title>Cordyceps Inhibits Apoptosis</title>
<p>A variety of kidney injury factors may trigger apoptosis, including ischemia/reperfusion injury (<xref ref-type="bibr" rid="B79">Xu et al., 2019</xref>), cisplatin-induced kidney injury (<xref ref-type="bibr" rid="B84">Yang et al., 2018</xref>), and DN (<xref ref-type="bibr" rid="B54">Peng et al., 2015</xref>). Apoptosis (a programmed cell death) of glomerular ECs, podocytes, and TECs is closely associated with RF (<xref ref-type="bibr" rid="B68">Thomas et al., 1998</xref>; <xref ref-type="bibr" rid="B16">Docherty et al., 2006</xref>). Inhibition of apoptosis as a therapeutic target can alleviate fibrosis (<xref ref-type="bibr" rid="B6">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="B78">Xia et al., 2021</xref>; <xref ref-type="bibr" rid="B53">Park et al., 2022</xref>). Cordyceps downregulates apoptosis in ischemia/reperfusion injury and Cyclosporine A&#x2013;induced renal tubular dysfunction (<xref ref-type="bibr" rid="B60">Shahed et al., 2001</xref>; <xref ref-type="bibr" rid="B9">Chyau et al., 2014</xref>). Apoptosis is also considered an important mechanism in contrast-induced nephropathy (CIN). <italic>C. sinensis</italic> prevents CIN in diabetic rats by decreasing the expression of apoptosis-related proteins Caspase-3 and Bax and increasing the expression of antiapoptotic protein Bcl-2. Mechanistically, <italic>C. sinensis</italic> decreases the expression of JNK protein and increases the expression of ERK protein (<xref ref-type="bibr" rid="B91">Zhao et al., 2018</xref>). Renal tubular interstitial fibrosis is a typical pathological feature of hypertensive kidney injury. In a spontaneous hypertension rat model, <italic>C. cicadae</italic> reduces interstitial fiber deposition, &#x3b1;-SMA expression, apoptosis, and Caspase-3 activity by regulating the SIRT1/p53 signaling pathway (<xref ref-type="bibr" rid="B25">Huang et al., 2020</xref>). <italic>In vitro</italic>, the major renal damage caused by hepatitis B virus infection is hepatitis B virus X (HBx)&#x2013;induced apoptosis of renal TECs, which is related to the increased Caspase-3 and Caspase-9 activity and increased PI3K/Akt pathway activity. <italic>C. sinensis</italic> attenuates all of these HBx-induced responses, at least in part by inhibiting the PI3K/Akt signaling pathway (<xref ref-type="bibr" rid="B23">He et al., 2020</xref>). Cordyceps and related products have been shown to inhibit apoptosis <italic>in vivo</italic> and <italic>in vitro</italic>, but the mechanisms involved have not been unified.</p>
</sec>
<sec id="s2-4">
<title>Cordyceps Regulates Autophagy</title>
<p>Autophagy is a &#x201c;self-consuming&#x201d; cell death pathway that degrades most cytoplasmic components by forming autophagosomes and autolysosomes (<xref ref-type="bibr" rid="B86">Yang and Klionsky, 2010</xref>). Basal autophagy in the kidney is critical for maintaining renal homeostasis, structure, and function. Namely, basal autophagy removes potentially dysfunctional organelles and long-lived proteins to maintain cellular homeostasis. In response to environmental and intracellular stress, autophagy may serve as an adaptive response to ensure cell survival. However, autophagy may also play a role in cellular dysfunction and organ lesions (<xref ref-type="bibr" rid="B67">Tang et al., 2020</xref>), such as AKI (<xref ref-type="bibr" rid="B27">Kaushal and Shah, 2016</xref>), AKI-CKD (<xref ref-type="bibr" rid="B3">Baisantry et al., 2016</xref>), and DN (<xref ref-type="bibr" rid="B29">Lenoir et al., 2015</xref>). The role of autophagy in RF is controversial. It has been reported that sustained activation of autophagy in renal tubular cells promotes interstitial fibrosis, and inhibition of autophagy with chloroquine or selective deletion of Atg7 in proximal tubules alleviates RF in UUO mice (<xref ref-type="bibr" rid="B40">Livingston et al., 2016</xref>). Several studies have also reported antifibrotic effects of autophagy, whereas inhibition of autophagy by 3-methyladenine exacerbated RF in a UUO rat model, suggesting that autophagy may exert antifibrotic effects by attenuating renal tubular cell injury (<xref ref-type="bibr" rid="B28">Kim et al., 2012</xref>). In STZ-induced DN mice, <italic>C. militaris</italic> polysaccharides (CMP) decrease collagen deposition in the kidney and increase the rate of autophagy; promote the expression of autophagy-specific protein Atg5, Beclin1, and LC3; and decrease the expression of p62 protein in the kidney. This suggests that CMP administration significantly enhances autophagy (<xref ref-type="bibr" rid="B7">Chen et al., 2019a</xref>). In a hypertensive nephropathy model, <italic>Cordyceps cicadae</italic> may attenuate the expression of fibrosis-associated proteins. It ameliorates RF induced by hypertension by downregulating autophagy-related proteins LC3II and Beclin-1, thereby significantly inhibiting autophagic vesicles and attenuating autophagic stress. This effect may be attributed to the regulation of SIRT1 pathway-mediated autophagic stress and is achieved by modulating the autophagy regulator forkhead box class O3a (FOXO3a) and oxidative stress (<xref ref-type="bibr" rid="B5">Cai et al., 2021</xref>). The regulatory effect of Cordyceps on autophagy is indisputable, but autophagy itself is diverse and can be divided into microautophagy, chaperone-mediated autophagy, and macroautophagy, and macroautophagy can be divided into nonselective autophagy and selective autophagy depending on whether the substrate is selective or not. Because autophagy is environment dependent and may play different roles at different stages of the disease, different cell types do not respond consistently to the autophagy activation, resulting in a bidirectional effect of cellular autophagy on the process of RF. The regulatory role of autophagy in fibrosis remains to be further investigated.</p>
</sec>
<sec id="s2-5">
<title>Cordyceps Reduces Extracellular Matrix Deposition and Fibroblast Activation</title>
<p>Aberrant activation and proliferation of fibroblasts are believed to be key causes of the progression of RF (<xref ref-type="bibr" rid="B94">Zhou et al., 2017</xref>). Activated fibroblasts, which promote the production and release of ECM collagens I, III, and IV and fibronectin (<xref ref-type="bibr" rid="B66">Sun et al., 2016</xref>), are the main source of ECM during scar tissue formation. Myofibroblasts in RF can be derived from mesenchymal fibroblasts, bone marrow&#x2013;derived fibroblasts, renal TECs, ECs, pericytes, and macrophages. TECs can produce stroma through the EMT to fibroblasts and myofibroblasts (<xref ref-type="bibr" rid="B83">Yan et al., 2021</xref>). In this process, TGF-&#x3b2; is the main driving factor. TGF-&#x3b2; induces fibroblast activation and proliferation as well as excessive synthesis and accumulation of ECM through downstream signaling pathways such as SMAD, BMMP-7, and CTGF, thereby promoting fibrosis. Targeted inhibition of TGF-&#x3b2; and its downstream signaling pathways delay fibrosis (<xref ref-type="bibr" rid="B48">Meng et al., 2016</xref>; <xref ref-type="bibr" rid="B73">Walton et al., 2017</xref>; <xref ref-type="bibr" rid="B45">Ma and Meng, 2019</xref>). In STZ-induced diabetic mice and high glucose&#x2013;exposed HK-2 cells, the nucleoside/nucleobase&#x2013;rich extract from Cordyceps increased E-cadherin expression; decreased &#x3b1;-SMA, fibronectin, and collagen I expression; inhibited EMT and ECM deposition; and improved the fibrotic morphology of tissues and cells. Cordyceps extract effectively inhibited the phosphorylation of p38 and ERK, did not affect the phosphorylation level of JNK, and had a synergistic effect on fibrosis with p38 or ERK inhibitors (<xref ref-type="bibr" rid="B17">Dong et al., 2019</xref>). Ergosterol peroxide from <italic>Cordyceps cicadae</italic> improves TGF-&#x3b2;1-induced renal fibroblast activation <italic>via</italic> the mitogen-activated protein kinases signaling pathway (<xref ref-type="bibr" rid="B97">Zhu et al., 2014</xref>). In DN C57BL/6J mice and 5/6 nephrectomy rats, <italic>C. militaris</italic> (<xref ref-type="bibr" rid="B88">Yu et al., 2016</xref>) and <italic>C. sinensis</italic> (<xref ref-type="bibr" rid="B52">Pan et al., 2013</xref>) counteracted RF and reduced the expression of fibrosis-associated proteins by inhibiting the TGF-&#x3b2;1 pathway. Further exploring downstream mechanisms, 3&#x2032;-deoxyadenosine interfered with TGF-&#x3b2; and bone morphogenetic protein signaling by downregulating Smads at the transcriptional level. In that way, it induced decreases in collagen I and &#x3b1;-SMA, mesenchymal myofibroblast number, and fibrotic area (<xref ref-type="bibr" rid="B21">Gu et al., 2013</xref>). Cordyceps and its extracts are potential therapeutic strategies against fibrosis <italic>via</italic> the TGF-&#x3b2;/Smad and other pathways.</p>
</sec>
<sec id="s2-6">
<title>Other Mechanisms</title>
<p>In addition to the above mechanisms, <italic>C. sinensis</italic> attenuates RF in the UUO model by inhibiting Bcl-2-associated athanogene 3 (BAG3), which has been reported to be involved in cell proliferation, apoptosis, adhesion and migration, and EMT processes (<xref ref-type="bibr" rid="B18">Du et al., 2015</xref>).</p>
<p>Recent studies have reported that gut microbiota mediates RF (<xref ref-type="bibr" rid="B38">Liu et al., 2021</xref>). CMP reduce renal injury by regulating intestinal flora imbalance (<xref ref-type="bibr" rid="B64">Song and Zhu, 2020</xref>). In a study of CCP to attenuate fibrosis in DN, high-throughput pyrophosphate sequencing of 16S rRNA indicated that CCP regulated dysbiosis of the intestinal flora by increasing the relative abundance and proliferation of probiotic bacteria, thereby exerting a beneficial effect on tubulointerstitial fibrosis in DN rats (<xref ref-type="bibr" rid="B85">Yang et al., 2020</xref>).</p>
<p>Normal energy metabolism is particularly important for maintaining the structure and function of the kidney, and metabolic reprogramming is generally considered a key process in activating fibrosis in different organs, as it is in the kidney (<xref ref-type="bibr" rid="B4">Barcena-Varela et al., 2021</xref>). The balance of fatty acid oxidation and glycolysis directly affects ECM production and degradation or indirectly affects RF through inflammation and hypoxia (<xref ref-type="bibr" rid="B98">Zhu et al., 2021</xref>). Metabolomic analysis has been used to explore the metabolic regulatory effects of <italic>C. sinensis</italic> in a db/db diabetic mice model. <italic>Hirsutella sinensis</italic>&#x2014;the anamorph of the traditional Chinese medicine <italic>C. sinensis</italic>&#x2014;attenuates RF, ameliorates system-wide disorders of glucolipid metabolism and amino acid deficiency, and regulates excessive activation energy and nucleotide metabolism (<xref ref-type="bibr" rid="B43">Lu et al., 2019</xref>). This suggests that Cordyceps may have a potential role in the regulation of renal metabolism and, consequently, may ameliorate fibrosis.</p>
</sec>
</sec>
<sec id="s3">
<title>Clinical Studies of Cordyceps and Related Products in Treating Chronic Kidney Diseases</title>
<p>In this section, we review published clinical studies of Cordyceps and related products, including two randomized controlled trial (RCT) studies, one cohort study, one review, and four meta-analyses (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p>One study recruited 98 patients with CKD3 or CKD4 and randomized them to the Cordycepin group (COG, patients received 100&#xa0;mg of <italic>C. militaris</italic> per day) and the control group (CG, patients received dried chickweed herb placebo per day). After 3&#xa0;months of treatment, <italic>C. militaris</italic> improved the inflammatory status and thickness of the glomerular filtration membrane of renal tissues. Compared with the CG group, the COG group had lower CKD biomarkers (<italic>p</italic> &#x3c; 0.05); higher EGFR (<italic>p</italic> &#x3c; 0.05); lower serum Cys-C, MPO, and MDA levels; and higher NO and SOD levels (<italic>p</italic> &#x3c; 0.05). <italic>C. sinensis</italic> reduced protein and mRNA levels of the TLR4/NF-&#x3ba;B signaling pathway (<italic>p</italic> &#x3c; 0.05). This suggests that <italic>C. militaris</italic> improves CKD by affecting the TLR4/NF-&#x3ba;B redox signaling pathway (<xref ref-type="bibr" rid="B65">Sun et al., 2019</xref>).</p>
<p>To evaluate the efficacy of the Cordyceps preparation Bailing capsule combined with losartan in the treatment of diabetic GS, a cohort that included 160 patients with diabetic GS was randomly divided into the observation and the CGs; the observation group was treated with losartan and Bailing capsules, and the CG was treated with losartan. The overall effective rate was higher in the observation group than in the CG (<italic>p</italic> &#x3c; 0.05). After the treatment, the DBP, SBP, Scr, 24&#xa0;h UP, BUN, mALB, and &#x3b2;2-MG levels were lower, and the GFR was higher in the observation group than in the CG (<italic>p</italic> &#x3c; 0.01). The traditional Chinese medicine symptom scores were lower in the observation group than in the CG (<italic>p</italic> &#x3c; 0.01). The observation group also showed higher serum SOD and lower ROS, 8-OHdG, hs-CRP, TGF-&#x3b2;1, and SAA levels than the control group (<italic>p</italic> &#x3c; 0.01). Bailing capsules combined with losartan improved the efficacy; improved the blood and urine biochemical indexes, the renal function, and the clinical symptoms; and reduced the oxidative stress. However, this study has the disadvantages of small sample size, short follow-up time, and bias in case selection (<xref ref-type="bibr" rid="B89">Yu et al., 2021</xref>).</p>
<p>In another review, 22 studies involving 1,746 participants were included. <italic>C. sinensis</italic> was found to significantly reduce Scr, increase creatinine clearance, and reduce 24 h proteinuria in patients with CKD. All 22 studies were published in Chinese and conducted in Chinese hospitals. The quality of evidence from the included trials in the evaluation was suboptimal; namely, four trials had a high risk of bias because of the lack of clear description of randomization, allocation concealment, and blinding, whereas the remaining 18 trials had an unclear risk of bias. In some of the included trials, there was significant heterogeneity in the conventional treatment as a co-intervention. Since there was no blinding during the study, possible differences in the multiple combined interventions between the treatment and control groups may have introduced bias into the results. Therefore, the poor methodological quality and underreporting of the included studies meant that no definitive conclusions could be drawn regarding the possible effects of Cordyceps preparations in patients with CKD (<xref ref-type="bibr" rid="B90">Zhang et al., 2014</xref>).</p>
<p>Four meta-analyses on Cordyceps preparations (JinShuiBao capsule/Bailing capsule) for DN included 51 RCT studies consisting of 3,955 participants (<xref ref-type="bibr" rid="B32">Li and Xu, 2020</xref>), 26 RCT studies with 2,198 early DN participants (<xref ref-type="bibr" rid="B42">Lu et al., 2018</xref>), 60 studies with 4,288 participants (<xref ref-type="bibr" rid="B44">Luo et al., 2015</xref>), and 24 studies with 1,941 participants (<xref ref-type="bibr" rid="B61">Sheng et al., 2020</xref>). All four studies showed that the Cordyceps preparation combined with ACEI/ARB was superior to ACEI/ARB alone, as shown by increased overall response rate and decreased 24 h UTP, UAER, BUN, and Scr. None of the studies had serious publication bias. However, all of the participating patients were Chinese with no other ethnicity; most of the included RCTs did not report detailed methodologies; in addition, efficacy assessments were not standardized and rigorous. The low quality of the study design and significant heterogeneity reduced the credibility of the meta-analysis.</p>
<p>To assess the safety of <italic>C. cicadae</italic>, 97 healthy adults were randomized to the treatment group (<italic>n</italic> &#x3d; 49) and the placebo group (<italic>n</italic> &#x3d; 48) in a double-blind, randomized trial. The treatment group received 1.05&#xa0;g of <italic>C. cicadae</italic> mycelium granules once a day after a meal for 3&#xa0;months. The placebo group received 1.05&#xa0;g granules with the same nutrition, but without additional <italic>C. cicadae</italic> mycelium. Blood samples were collected before and after the treatment for biochemical analysis, including renal function, liver function, blood lipid, and electrolyte levels. No differences in symptoms or side effects were observed between the participants in the trial. There were also no significant differences between the baseline measurements and the final biochemical analyses. The results of the trial indicate that it is safe to consume less than 1.05&#xa0;g of HEA-rich mycelium per day (<xref ref-type="bibr" rid="B70">Tsai et al., 2021</xref>).</p>
<p>In addition to single drugs or extracts, there are many compound preparations of Chinese herbs; some of the compound formulations of Cordyceps also have renal protective effects. WH30&#x2b; is a Chinese herb preparation composed of <italic>Rheum palmatum</italic>, <italic>S. miltiorrhiza</italic>, <italic>C. sinensis</italic>, <italic>Leonurus sibiricus</italic>, <italic>Epihedium macranthum</italic>, Radix Astragali, and Radix Codonopsis Pilosulae. It has nephroprotective effects in both glycerol-induced acute renal failure and adenine-induced chronic renal failure rats (<xref ref-type="bibr" rid="B49">Ngai et al., 2005</xref>). Cordyceps-related formulations of Novel JY5 formula (<xref ref-type="bibr" rid="B19">Fu et al., 2021</xref>), CGA formula (<xref ref-type="bibr" rid="B31">Li et al., 2016</xref>; <xref ref-type="bibr" rid="B69">Tian et al., 2019</xref>), and Fuzheng Huayu formula (<xref ref-type="bibr" rid="B8">Chen et al., 2019b</xref>) all have good effects against liver fibrosis, suggesting that these formulations may also be potential novel therapeutic candidates for RF.</p>
</sec>
<sec id="s4">
<title>Conclusion and Perspective</title>
<p>In this study, we found that Cordyceps and related products could attenuate RF through multiple pathways and targets, but the mechanisms were not independent of each other. Targeting TLR4 could reduce inflammation and oxidative stress <italic>via</italic> NF-&#x3ba;B or activate the downstream TGF-&#x3b2;/Smad signaling pathway to promote ECM deposition and fibroblast activation. Acting on SIRT1 was important in the regulation of autophagy, oxidative stress, energy homeostasis, and apoptosis. Although multitargeting had certain advantages, it could also have more side effects. Toxic side effects associated with Cordyceps have been reported in animals and humans. <italic>C. militaris</italic> was administered to rats at doses of 0, 1, 2, and 3&#xa0;g/kg per day. Nephrotoxicity characterized by renal tubular epithelial degeneration and necrosis occurred at high doses of 3&#xa0;g/kg, and the male rats were more susceptible to nephrotoxicity than female rats (<xref ref-type="bibr" rid="B96">Zhou and Yao, 2013</xref>). Doan et al. reported 60 cases of apparent Cordyceps fungus poisoning occurring in southern Vietnam during the rainy seasons, between 2008 and 2015. All patients showed symptoms within 60&#xa0;min of consuming cicada flowers. A 60-year-old male patient died after consuming five cicada flowers and ingesting approximately 200&#xa0;ml of rice wine. Another patient ingested 15&#x2013;16 cicada flowers; although he exhibited severe symptoms, he survived after 3&#xa0;weeks of treatment. These observations suggest that there are individual differences in the doses of cicada flower poisoning (<xref ref-type="bibr" rid="B15">Doan et al., 2017</xref>). It is therefore crucial to establish more systematic, complete, and feasible pharmacological and toxicological research methods.</p>
<p>Based on the available preclinical studies, Cordyceps and related products are supported for the treatment of RF. However, the available clinical data are limited. The published study protocol has been improved (<xref ref-type="bibr" rid="B24">Hu et al., 2021</xref>); as such, future RCTs with good methodological quality, favorable experimental design, and large sample size are needed to explore the therapeutic effects of Cordyceps and related products on RF to provide more rigorous clinical study data.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Author Contributions</title>
<p>WT and YW designed the work of review. HD, JD, ZW, and LL reviewed the literature available on this topic, WT and YW wrote the paper, WT and JY revised the manuscript. All authors approved the paper for publication. As the leader of the project team, JY won the research funding supporting this manuscript.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>This project is supported by the Chongqing Talent Program Project (cstc2021ycjh-bgzxm0090).</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aranda-Rivera</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Cruz-Gregorio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aparicio-Trejo</surname>
<given-names>O. E.</given-names>
</name>
<name>
<surname>Ortega-Lozano</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Pedraza-Chaverri</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Redox Signaling Pathways in Unilateral Ureteral Obstruction (UUO)-induced Renal Fibrosis</article-title>. <source>Free Radic. Biol. Med.</source> <volume>172</volume>, <fpage>65</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2021.05.034</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Pirfenidone Is a Renal Protective Drug: Mechanisms, Signalling Pathways, and Preclinical Evidence</article-title>. <source>Eur. J. Pharmacol.</source> <volume>911</volume>, <fpage>174503</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2021.174503</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baisantry</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bhayana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ermeling</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wrede</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hegermann</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Autophagy Induces Prosenescent Changes in Proximal Tubular S3 Segments</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>27</volume> (<issue>6</issue>), <fpage>1609</fpage>&#x2013;<lpage>1616</lpage>. <pub-id pub-id-type="doi">10.1681/asn.2014111059</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barcena-Varela</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paish</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Uriarte</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Latasa</surname>
<given-names>M. U.</given-names>
</name>
<name>
<surname>Santamaria</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Epigenetic Mechanisms and Metabolic Reprogramming in Fibrogenesis: Dual Targeting of G9a and DNMT1 for the Inhibition of Liver Fibrosis</article-title>. <source>Gut</source> <volume>70</volume> (<issue>2</issue>), <fpage>388</fpage>&#x2013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2019-320205</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cordyceps Cicadae Ameliorates Renal Hypertensive Injury and Fibrosis through the Regulation of SIRT1-Mediated Autophagy</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>801094</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.801094</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Protective Effects of Nootkatone on Renal Inflammation, Apoptosis, and Fibrosis in a Unilateral Ureteral Obstructive Mouse Model</article-title>. <source>Nutrients</source> <volume>13</volume> (<issue>11</issue>). <pub-id pub-id-type="doi">10.3390/nu13113921</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019a</year>). <article-title>Cordyceps Militaris Polysaccharides Exerted Protective Effects on Diabetic Nephropathy in Mice via Regulation of Autophagy</article-title>. <source>Food Funct.</source> <volume>10</volume> (<issue>8</issue>), <fpage>5102</fpage>&#x2013;<lpage>5114</lpage>. <pub-id pub-id-type="doi">10.1039/c9fo00957d</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2019b</year>). <article-title>The Effect and Mechanisms of Fuzheng Huayu Formula against Chronic Liver Diseases</article-title>. <source>Biomed. Pharmacother.</source> <volume>114</volume>, <fpage>108846</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.108846</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chyau</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Mycelia Glycoproteins from Cordyceps Sobolifera Ameliorate Cyclosporine-Induced Renal Tubule Dysfunction in Rats</article-title>. <source>J. Ethnopharmacol.</source> <volume>153</volume> (<issue>3</issue>), <fpage>650</fpage>&#x2013;<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2014.03.020</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chyau</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Potential Protection Effect of ER Homeostasis of N6-(2-Hydroxyethyl)adenosine Isolated from Cordyceps Cicadae in Nonsteroidal Anti-inflammatory Drug-Stimulated Human Proximal Tubular Cells</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>4</issue>). <pub-id pub-id-type="doi">10.3390/ijms22041577</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darby</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Hewitson</surname>
<given-names>T. D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Hypoxia in Tissue Repair and Fibrosis</article-title>. <source>Cell Tissue Res.</source> <volume>365</volume> (<issue>3</issue>), <fpage>553</fpage>&#x2013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-016-2461-3</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Leyva-G&#xf3;mez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Prado-Audelo</surname>
<given-names>M. L. D.</given-names>
</name>
<name>
<surname>Cortes</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>Y. D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cordyceps spp.: A Review on its Immune-Stimulatory and Other Biological Potentials</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>602364</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.602364</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W. P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P. Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cordyceps Cicadae Mycelia Ameliorate Cisplatin-Induced Acute Kidney Injury by Suppressing the TLR4/NF-&#x39a;b/MAPK and Activating the HO-1/Nrf2 and Sirt-1/AMPK Pathways in Mice</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2020</volume>, <fpage>7912763</fpage>. <pub-id pub-id-type="doi">10.1155/2020/7912763</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djudjaj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Boor</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cellular and Molecular Mechanisms of Kidney Fibrosis</article-title>. <source>Mol. Asp. Med.</source> <volume>65</volume>, <fpage>16</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2018.06.002</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doan</surname>
<given-names>U. V.</given-names>
</name>
<name>
<surname>Mendez Rojas</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Unintentional Ingestion of Cordyceps Fungus-Infected Cicada Nymphs Causing Ibotenic Acid Poisoning in Southern Vietnam</article-title>. <source>Clin. Toxicol. (Phila)</source> <volume>55</volume> (<issue>8</issue>), <fpage>893</fpage>&#x2013;<lpage>896</lpage>. <pub-id pub-id-type="doi">10.1080/15563650.2017.1319066</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Docherty</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>O&#x27;Sullivan</surname>
<given-names>O. E.</given-names>
</name>
<name>
<surname>Healy</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>R. W.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Evidence that Inhibition of Tubular Cell Apoptosis Protects against Renal Damage and Development of Fibrosis Following Ureteric Obstruction</article-title>. <source>Am. J. Physiol. Ren. Physiol.</source> <volume>290</volume> (<issue>1</issue>), <fpage>F4</fpage>&#x2013;<lpage>F13</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00045.2005</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A Nucleoside/Nucleobase-Rich Extract from Cordyceps Sinensis Inhibits the Epithelial-Mesenchymal Transition and Protects against Renal Fibrosis in Diabetic Nephropathy</article-title>. <source>Molecules</source> <volume>24</volume> (<issue>22</issue>). <pub-id pub-id-type="doi">10.3390/molecules24224119</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Zong</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z. X.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Cordyceps Sinensis Attenuates Renal Fibrosis and Suppresses BAG3 Induction in Obstructed Rat Kidney</article-title>. <source>Am. J. Transl. Res.</source> <volume>7</volume> (<issue>5</issue>), <fpage>932</fpage>&#x2013;<lpage>940</lpage>. </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>671152</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.671152</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gewin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zent</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pozzi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Progression of Chronic Kidney Disease: Too Much Cellular Talk Causes Damage</article-title>. <source>Kidney Int.</source> <volume>91</volume> (<issue>3</issue>), <fpage>552</fpage>&#x2013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2016.08.025</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Johno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Katoh</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Blockade of Smad Signaling by 3&#x27;-deoxyadenosine: a Mechanism for its Anti-fibrotic Potential</article-title>. <source>Lab. Invest.</source> <volume>93</volume> (<issue>4</issue>), <fpage>450</fpage>&#x2013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2013.4</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cordycepin Protects Renal Ischemia/reperfusion Injury through Regulating Inflammation, Apoptosis, and Oxidative Stress</article-title>. <source>Acta Biochim. Biophys. Sin. (Shanghai)</source> <volume>52</volume> (<issue>2</issue>), <fpage>125</fpage>&#x2013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmz145</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Cordyceps Sinensis Attenuates HBx-induced C-ell A-poptosis in&#xa0;HK-2 C-ells through S-uppressing the PI3K/Akt P-athway</article-title>. <source>Int. J. Mol. Med.</source> <volume>45</volume> (<issue>4</issue>), <fpage>1261</fpage>&#x2013;<lpage>1269</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2020.4503</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Bailing Capsule Combined with &#x3b1;-ketoacid Tablets for Stage 3 Chronic Kidney Disease</article-title>. <source>Med. Baltim.</source> <volume>100</volume> (<issue>20</issue>), <fpage>e25759</fpage>. <pub-id pub-id-type="doi">10.1097/md.0000000000025759</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cordyceps Cicadae Prevents Renal Tubular Epithelial Cell Apoptosis by Regulating the SIRT1/p53 Pathway in Hypertensive Renal Injury</article-title>. <source>Evid. Based Complement. Altern. Med.</source> <volume>2020</volume>, <fpage>7202519</fpage>. <pub-id pub-id-type="doi">10.1155/2020/7202519</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humphreys</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mechanisms of Renal Fibrosis</article-title>. <source>Annu. Rev. Physiol.</source> <volume>80</volume>, <fpage>309</fpage>&#x2013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034227</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaushal</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Autophagy in Acute Kidney Injury</article-title>. <source>Kidney Int.</source> <volume>89</volume> (<issue>4</issue>), <fpage>779</fpage>&#x2013;<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2015.11.021</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. L.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>The Role of Autophagy in Unilateral Ureteral Obstruction Rat Model</article-title>. <source>Nephrol. Carlt.</source> <volume>17</volume> (<issue>2</issue>), <fpage>148</fpage>&#x2013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1797.2011.01541.x</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenoir</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Jasiek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>H&#xe9;nique</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guyonnet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hartleben</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Endothelial Cell and Podocyte Autophagy Synergistically Protect from Diabetes-Induced Glomerulosclerosis</article-title>. <source>Autophagy</source> <volume>11</volume> (<issue>7</issue>), <fpage>1130</fpage>&#x2013;<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2015.1049799</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Potential Therapeutic Effects of Cordyceps Cicadae and Paecilomyces Cicadae on Adenine-Induced Chronic Renal Failure in Rats and Their Phytochemical Analysis</article-title>. <source>Drug Des. Devel Ther.</source> <volume>13</volume>, <fpage>103</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.2147/dddt.S180543</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Chinese Medicine CGA Formula Ameliorates DMN-Induced Liver Fibrosis in Rats via Inhibiting MMP2/9, TIMP1/2 and the TGF-&#x3b2;/Smad Signaling Pathways</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>37</volume> (<issue>6</issue>), <fpage>783</fpage>&#x2013;<lpage>793</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2016.35</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Clinical Efficacy and Safety of Jinshuibao Combined with ACEI/ARB in the Treatment of Diabetic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials</article-title>. <source>J. Ren. Nutr.</source> <volume>30</volume> (<issue>2</issue>), <fpage>92</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1053/j.jrn.2019.03.083</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps Sinensis on the Treatment of Diabetic Nephropathy</article-title>. <source>J. Diabetes Res.</source> <volume>2021</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1155/2021/8891093</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2022</volume>, <fpage>2453617</fpage>. <pub-id pub-id-type="doi">10.1155/2022/2453617</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Nowlin</surname>
<given-names>B. T.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Macrophage Wnt7b Is Critical for Kidney Repair and Regeneration</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>107</volume> (<issue>9</issue>), <fpage>4194</fpage>&#x2013;<lpage>4199</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0912228107</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liston</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Masters</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Homeostasis-altering Molecular Processes as Mechanisms of Inflammasome Activation</article-title>. <source>Nat. Rev. Immunol.</source> <volume>17</volume> (<issue>3</issue>), <fpage>208</fpage>&#x2013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.151</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>20162016</year>). <article-title>Antidiabetic and Antinephritic Activities of Aqueous Extract ofCordyceps militarisFruit Body in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats</article-title>. <source>Oxidative Med. Cell. Longev.</source> <volume>2016</volume>, <fpage>1</fpage>. <pub-id pub-id-type="doi">10.1155/2016/9685257</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>D. Q.</given-names>
</name>
<name>
<surname>Vaziri</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y. Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gut Microbiota-Derived Tryptophan Metabolism Mediates Renal Fibrosis by Aryl Hydrocarbon Receptor Signaling Activation</article-title>. <source>Cell Mol. Life Sci.</source> <volume>78</volume> (<issue>3</issue>), <fpage>909</fpage>&#x2013;<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-020-03645-1</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Signalling Pathways Involved in Hypoxia-Induced Renal Fibrosis</article-title>. <source>J. Cell Mol. Med.</source> <volume>21</volume> (<issue>7</issue>), <fpage>1248</fpage>&#x2013;<lpage>1259</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.13060</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livingston</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Persistent Activation of Autophagy in Kidney Tubular Cells Promotes Renal Interstitial Fibrosis during Unilateral Ureteral Obstruction</article-title>. <source>Autophagy</source> <volume>12</volume> (<issue>6</issue>), <fpage>976</fpage>&#x2013;<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2016.1166317</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Nobiletin Alleviates Ferroptosis-Associated Renal Injury, Inflammation, and Fibrosis in a Unilateral Ureteral Obstruction Mouse Model</article-title>. <source>Biomedicines</source> <volume>10</volume> (<issue>3</issue>). <pub-id pub-id-type="doi">10.3390/biomedicines10030595</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Clinical Efficacy of Jinshuibao Capsules Combined with Angiotensin Receptor Blockers in Patients with Early Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials</article-title>. <source>Evid. Based Complement. Altern. Med.</source> <volume>2018</volume>, <fpage>6806943</fpage>. <pub-id pub-id-type="doi">10.1155/2018/6806943</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Aa</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Hirsutella Sinensis Treatment Shows Protective Effects on Renal Injury and Metabolic Modulation in Db/db Mice</article-title>. <source>Evid. Based Complement. Altern. Med.</source> <volume>2019</volume>, <fpage>4732858</fpage>. <pub-id pub-id-type="doi">10.1155/2019/4732858</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Use of Ophiocordyceps Sinensis (Syn. Cordyceps Sinensis) Combined with Angiotensin-Converting Enzyme Inhibitors (ACEI)/angiotensin Receptor Blockers (ARB) versus ACEI/ARB Alone in the Treatment of Diabetic Kidney Disease: a Meta-Analysis</article-title>. <source>Ren. Fail</source> <volume>37</volume> (<issue>4</issue>), <fpage>614</fpage>&#x2013;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.3109/0886022x.2015.1009820</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>TGF-&#x3b2;/Smad and Renal Fibrosis</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1165</volume>, <fpage>347</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-13-8871-2_16</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Quercetin Ameliorates Renal Tubulointerstitial Transformation and Renal Fibrosis by Regulating NLRP3 in Obstructive Nephropathy</article-title>. <source>Minerva Med.</source>. <pub-id pub-id-type="doi">10.23736/s0026-4806.22.08104-6</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>X. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Inflammatory Mediators and Renal Fibrosis</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1165</volume>, <fpage>381</fpage>&#x2013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-13-8871-2_18</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>Nikolic-Paterson</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>H. Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>TGF-&#x3b2;: the Master Regulator of Fibrosis</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>12</volume> (<issue>6</issue>), <fpage>325</fpage>&#x2013;<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1038/nrneph.2016.48</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ngai</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Sit</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The Nephroprotective Effects of the Herbal Medicine Preparation, WH30&#x2b;, on the Chemical-Induced Acute and Chronic Renal Failure in Rats</article-title>. <source>Am. J. Chin. Med.</source> <volume>33</volume> (<issue>3</issue>), <fpage>491</fpage>&#x2013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1142/s0192415x05003089</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogueira</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>P. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies</article-title>. <source>Vivo</source> <volume>31</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.21873/invivo.11019</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olatunji</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tola</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Auberon</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Oluwaniyi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Genus Cordyceps: An Extensive Review of its Traditional Uses, Phytochemistry and Pharmacology</article-title>. <source>Fitoterapia</source> <volume>129</volume>, <fpage>293</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2018.05.010</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>A. O.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Inhibition of TGF-&#x3b2;1/Smad Signal Pathway Is Involved in the Effect of Cordyceps Sinensis against Renal Fibrosis in 5/6 Nephrectomy Rats</article-title>. <source>Food Chem. Toxicol.</source> <volume>58</volume>, <fpage>487</fpage>&#x2013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2013.04.037</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Blockade of STAT3 Signaling Alleviates the Progression of Acute Kidney Injury to Chronic Kidney Disease through Antiapoptosis</article-title>. <source>Am. J. Physiol. Ren. Physiol.</source> <volume>322</volume> (<issue>5</issue>), <fpage>F553</fpage>&#x2013;<lpage>f572</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00595.2020</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S. B.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Hyperglycemia, P53, and Mitochondrial Pathway of Apoptosis Are Involved in the Susceptibility of Diabetic Models to Ischemic Acute Kidney Injury</article-title>. <source>Kidney Int.</source> <volume>87</volume> (<issue>1</issue>), <fpage>137</fpage>&#x2013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2014.226</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phull</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Cordyceps Militaris as a Bio Functional Food Source: Pharmacological Potential, Anti-inflammatory Actions and Related Molecular Mechanisms</article-title>. <source>Microorganisms</source> <volume>10</volume> (<issue>2</issue>). <pub-id pub-id-type="doi">10.3390/microorganisms10020405</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ram</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gairola</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Kulhari</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mugale</surname>
<given-names>M. N.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Biochanin A Alleviates Unilateral Ureteral Obstruction-Induced Renal Interstitial Fibrosis and Inflammation by Inhibiting the TGF-&#x3b2;1/Smad2/3 and NF-kB/NLRP3 Signaling axis in Mice</article-title>. <source>Life Sci.</source> <volume>298</volume>, <fpage>120527</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2022.120527</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricardo</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>van Goor</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Eddy</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Macrophage Diversity in Renal Injury and Repair</article-title>. <source>J. Clin. Invest.</source> <volume>118</volume> (<issue>11</issue>), <fpage>3522</fpage>&#x2013;<lpage>3530</lpage>. <pub-id pub-id-type="doi">10.1172/jci36150</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richter</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kietzmann</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Reactive Oxygen Species and Fibrosis: Further Evidence of a Significant Liaison</article-title>. <source>Cell Tissue Res.</source> <volume>365</volume> (<issue>3</issue>), <fpage>591</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-016-2445-3</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz-Ortega</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lamas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Antifibrotic Agents for the Management of CKD: A Review</article-title>. <source>Am. J. Kidney Dis.</source> <volume>S0272-6386</volume> (<issue>21</issue>), <fpage>01051</fpage>&#x2013;<lpage>01059</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2021.11.010</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahed</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Shoskes</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Down-regulation of Apoptotic and Inflammatory Genes by Cordyceps Sinensis Extract in Rat Kidney Following Ischemia/reperfusion</article-title>. <source>Transpl. Proc.</source> <volume>33</volume> (<issue>6</issue>), <fpage>2986</fpage>&#x2013;<lpage>2987</lpage>. <pub-id pub-id-type="doi">10.1016/s0041-1345(01)02282-5</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Efficacy and Safety of Bailing Capsules in the Treatment of Type 2 Diabetic Nephropathy: a Meta-Analysis</article-title>. <source>Ann. Palliat. Med.</source> <volume>9</volume> (<issue>6</issue>), <fpage>3885</fpage>&#x2013;<lpage>3898</lpage>. <pub-id pub-id-type="doi">10.21037/apm-20-1799</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Berndt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Oxidative Stress</article-title>. <source>Annu. Rev. Biochem.</source> <volume>86</volume>, <fpage>715</fpage>&#x2013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-045037</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Cordyceps Militaris Fruit Body Extract Ameliorates Membranous Glomerulonephritis by Attenuating Oxidative Stress and Renal Inflammation via the NF-&#x39a;b Pathway</article-title>. <source>Food Funct.</source> <volume>7</volume> (<issue>4</issue>), <fpage>2006</fpage>&#x2013;<lpage>2015</lpage>. <pub-id pub-id-type="doi">10.1039/c5fo01017a</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Using Cordyceps Militaris Extracellular Polysaccharides to Prevent Pb2&#x2b;-Induced Liver and Kidney Toxicity by Activating Nrf2 Signals and Modulating Gut Microbiota</article-title>. <source>Food Funct.</source> <volume>11</volume> (<issue>10</issue>), <fpage>9226</fpage>&#x2013;<lpage>9239</lpage>. <pub-id pub-id-type="doi">10.1039/d0fo01608j</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Cordyceps Militaris Improves Chronic Kidney Disease by Affecting TLR4/NF-&#x39a;b Redox Signaling Pathway</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2019</volume>, <fpage>7850863</fpage>. <pub-id pub-id-type="doi">10.1155/2019/7850863</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Caruana</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The Origin of Renal Fibroblasts/myofibroblasts and the Signals that Trigger Fibrosis</article-title>. <source>Differentiation</source> <volume>92</volume> (<issue>3</issue>), <fpage>102</fpage>&#x2013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.diff.2016.05.008</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Livingston</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Autophagy in Kidney Homeostasis and Disease</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>16</volume> (<issue>9</issue>), <fpage>489</fpage>&#x2013;<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-020-0309-2</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Savill</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>El Nahas</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Cellular Apoptosis and Proliferation in Experimental Renal Fibrosis</article-title>. <source>Nephrol. Dial. Transpl.</source> <volume>13</volume> (<issue>9</issue>), <fpage>2216</fpage>&#x2013;<lpage>2226</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/13.9.2216</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Chinese Medicine CGA Formula Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride Involving Inhibition of Hepatic Apoptosis in Rats</article-title>. <source>J. Ethnopharmacol.</source> <volume>232</volume>, <fpage>227</fpage>&#x2013;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2018.11.027</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Safety Assessment of HEA-Enriched Cordyceps Cicadae Mycelium: A Randomized Clinical Trial</article-title>. <source>J. Am. Coll. Nutr.</source> <volume>40</volume> (<issue>2</issue>), <fpage>127</fpage>&#x2013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1080/07315724.2020.1743211</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincenti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fervenza</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gesualdo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis</article-title>. <source>Kidney Int. Rep.</source> <volume>2</volume> (<issue>5</issue>), <fpage>800</fpage>&#x2013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1016/j.ekir.2017.03.011</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voelker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Sheetz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duffin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Anti-TGF-&#x3b2;1 Antibody Therapy in Patients with Diabetic Nephropathy</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>28</volume> (<issue>3</issue>), <fpage>953</fpage>&#x2013;<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1681/asn.2015111230</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Targeting TGF-&#x3b2; Mediated SMAD Signaling for the Prevention of Fibrosis</article-title>. <source>Front. Pharmacol.</source> <volume>8</volume>, <fpage>461</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00461</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Rui</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Artificially Cultivated Ophiocordyceps Sinensis Alleviates Diabetic Nephropathy and its Podocyte Injury via Inhibiting P2X7R Expression and NLRP3 Inflammasome Activation</article-title>. <source>J. Diabetes Res.</source> <volume>2018</volume>, <fpage>1390418</fpage>. <pub-id pub-id-type="doi">10.1155/2018/1390418</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>C. C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>790937</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.790937</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Olatunji</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>N6 -(2-Hydroxyethyl)-Adenosine from Cordyceps Cicadae Protects against Diabetic Kidney Disease via Alleviation of Oxidative Stress and Inflammation</article-title>. <source>J. Food Biochem.</source> <volume>43</volume> (<issue>2</issue>), <fpage>e12727</fpage>. <pub-id pub-id-type="doi">10.1111/jfbc.12727</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wojcikowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Gob&#xe9;</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Medicinal Herbal Extracts-Rrenal Friend or Foe? Part Two: Herbal Extracts with Potential Renal Benefits</article-title>. <source>Nephrol. Carlt.</source> <volume>9</volume> (<issue>6</issue>), <fpage>400</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1797.2004.00355.x</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>W. P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ru</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Knockdown of lncRNA XIST Inhibited Apoptosis and Inflammation in Renal Fibrosis via microRNA-19b-Mediated Downregulation of SOX6</article-title>. <source>Mol. Immunol.</source> <volume>139</volume>, <fpage>87</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2021.07.012</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. Z.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>c-Myc Promotes Tubular Cell Apoptosis in Ischemia-Reperfusion-Induced Renal Injury by Negatively Regulating C-FLIP and Enhancing FasL/Fas-Mediated Apoptosis Pathway</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>40</volume> (<issue>8</issue>), <fpage>1058</fpage>&#x2013;<lpage>1066</lpage>. <pub-id pub-id-type="doi">10.1038/s41401-018-0201-9</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Progress of Inflammation and Oxidative Stress in Patients with Chronic Kidney Disease</article-title>. <source>Ren. Fail</source> <volume>37</volume> (<issue>1</issue>), <fpage>45</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.3109/0886022x.2014.964141</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Hepatoprotective Effect of Genistein against Dimethylnitrosamine-Induced Liver Fibrosis in Rats by Regulating Macrophage Functional Properties and Inhibiting the JAK2/STAT3/SOCS3 Signaling Pathway</article-title>. <source>Front. Biosci. (Landmark Ed.</source> <volume>26</volume> (<issue>12</issue>), <fpage>1572</fpage>&#x2013;<lpage>1584</lpage>. <pub-id pub-id-type="doi">10.52586/5050</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Enosi Tuipulotu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Man</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Emerging Activators and Regulators of Inflammasomes and Pyroptosis</article-title>. <source>Trends Immunol.</source> <volume>40</volume> (<issue>11</issue>), <fpage>1035</fpage>&#x2013;<lpage>1052</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2019.09.005</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Defining Therapeutic Targets for Renal Fibrosis: Exploiting the Biology of Pathogenesis</article-title>. <source>Biomed. Pharmacother.</source> <volume>143</volume>, <fpage>112115</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2021.112115</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X. J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H. X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Asiatic Acid Protects against Cisplatin-Induced Acute Kidney Injury via Anti-apoptosis and Anti-inflammation</article-title>. <source>Biomed. Pharmacother.</source> <volume>107</volume>, <fpage>1354</fpage>&#x2013;<lpage>1362</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.08.126</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cordyceps Cicadae Polysaccharides Ameliorated Renal Interstitial Fibrosis in Diabetic Nephropathy Rats by Repressing Inflammation and Modulating Gut Microbiota Dysbiosis</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>163</volume>, <fpage>442</fpage>&#x2013;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.06.153</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Klionsky</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Eaten Alive: a History of Macroautophagy</article-title>. <source>Nat. Cell Biol.</source> <volume>12</volume> (<issue>9</issue>), <fpage>814</fpage>&#x2013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1038/ncb0910-814</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ying-Mei</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shu-Bo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y. U.</given-names>
</name>
<name>
<surname>Juan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Component Analysis of Ophiocordyceps Lanpingensis Polysaccharides and Study on Alleviation of Hepatic Fibrosis in Mice by Polysaccharides</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source> <volume>45</volume> (<issue>21</issue>), <fpage>5256</fpage>&#x2013;<lpage>5264</lpage>. <pub-id pub-id-type="doi">10.19540/j.cnki.cjcmm.20200628.401</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Dubey</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Leu</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Cordyceps Militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice</article-title>. <source>PLoS One</source> <volume>11</volume> (<issue>11</issue>), <fpage>e0166342</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0166342</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Effect of Bailing Capsules Combined with Losartan to Treat Diabetic Glomerulosclerosis and the Combination&#x27;s Effect on Blood and Urine Biochemistry</article-title>. <source>Am. J. Transl. Res.</source> <volume>13</volume> (<issue>6</issue>), <fpage>6873</fpage>&#x2013;<lpage>6880</lpage>. </citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z. X.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Cordyceps Sinensis (A Traditional Chinese Medicine) for Treating Chronic Kidney Disease</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>12</volume>, <fpage>Cd008353</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD008353.pub2</pub-id> </citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Cordyceps Sinensis Prevents Contrast-Induced Nephropathy in Diabetic Rats: its Underlying Mechanism</article-title>. <source>Int. J. Clin. Exp. Pathol.</source> <volume>11</volume> (<issue>12</issue>), <fpage>5571</fpage>&#x2013;<lpage>5580</lpage>. </citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>619201</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.619201</pub-id> </citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>N6-(2-Hydroxyethyl) Adenosine from Cordyceps Cicadae Ameliorates Renal Interstitial Fibrosis and Prevents Inflammation via TGF-&#x3b2;1/Smad and NF-&#x39a;b Signaling Pathway</article-title>. <source>Front. Physiol.</source> <volume>9</volume>, <fpage>1229</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2018.01229</pub-id> </citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Tubule-Derived Wnts Are Required for Fibroblast Activation and Kidney Fibrosis</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>28</volume> (<issue>8</issue>), <fpage>2322</fpage>&#x2013;<lpage>2336</lpage>. <pub-id pub-id-type="doi">10.1681/asn.2016080902</pub-id> </citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Ophiocordyceps Lanpingensis Polysaccharides Alleviate Chronic Kidney Disease through MAPK/NF-&#x3ba;B Pathway</article-title>. <source>J. Ethnopharmacol.</source> <volume>276</volume>, <fpage>114189</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2021.114189</pub-id> </citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Unexpected Nephrotoxicity in Male Ablactated Rats Induced by Cordyceps Militaris: The Involvement of Oxidative Changes</article-title>. <source>Evid. Based Complement. Altern. Med.</source> <volume>2013</volume>, <fpage>786528</fpage>. <pub-id pub-id-type="doi">10.1155/2013/786528</pub-id> </citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Ergosterol Peroxide from Cordyceps Cicadae Ameliorates TGF-&#x392;1-Induced Activation of Kidney Fibroblasts</article-title>. <source>Phytomedicine</source> <volume>21</volume> (<issue>3</issue>), <fpage>372</fpage>&#x2013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2013.08.022</pub-id> </citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Metabolic Reprogramming and Renal Fibrosis</article-title>. <source>Front. Med.</source> <volume>8</volume>, <fpage>746920</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2021.746920</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>